The involvement of catecholamines, in hypertension, alcohol and ACE-inhibition.
Patel
V B
VB
Department of Clinical Biochemistry, King's College School of Medicine & Dentistry, London, UK.
Watson
L
L
Mathias
C J
CJ
Richardson
P J
PJ
Preedy
V R
VR
D000437:Alcoholism / Q000378:metabolism / Q000503:physiopathology*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D001794:Blood Pressure; D002395:Catecholamines / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism; D004837:Epinephrine / Q000378:metabolism; D006321:Heart / Q000187:drug effects*; D006973:Hypertension / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology*; D017706:Lisinopril / Q000494:pharmacology* / Q000627:therapeutic use; D008297:Male; D009206:Myocardium / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D012016:Reference Values
D000806:Angiotensin-Converting Enzyme Inhibitors; D002395:Catecholamines; D017706:Lisinopril; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine